Electrophoresis Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Laboratories is the fastest growing sector, North America is the largest market

The global market for electrophoresis reagents is projected to expand from USD 2.93 billion in 2025 to USD 4.14 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 5.93%. These reagents, which include gels, buffers, and stains, are specialized chemical compounds essential for separating macromolecules like DNA, RNA, and proteins in laboratory analyses based on their physical attributes. This market growth is chiefly driven by the increasing need for personalized medicine and the rise in genomic research, both of which necessitate precise molecular separation for applications in drug discovery and diagnostics. For instance, the European pharmaceutical industry's €55 billion investment in R&D in 2024, as reported by the European Federation of Pharmaceutical Industries and Associations, establishes a strong financial foundation that directly supports the substantial consumption of these crucial laboratory consumables.

However, despite this promising growth, the market faces a considerable hurdle due to the growing preference for alternative analytical technologies. Advanced techniques such as Next-Generation Sequencing (NGS) and High-Performance Liquid Chromatography (HPLC) are gaining traction for high-throughput applications, posing a competitive challenge that may restrict the ongoing use of traditional electrophoresis methods in sophisticated research environments.

Market Drivers

The increasing incidence of chronic and infectious diseases serves as a primary driver for the Global Electrophoresis Reagents Market, as these conditions demand advanced diagnostic and research instruments. Electrophoresis is increasingly employed by laboratories for the accurate separation of nucleic acids and proteins, enabling the identification of biomarkers linked to intricate diseases like cancer and tuberculosis. For example, the American Cancer Society's 'Cancer Facts & Figures 2025' projected 2,041,910 new cancer diagnoses in the United States alone in January 2025, thereby boosting the demand for reagents used in genomic profiling and proteomic analysis. Likewise, the persistent global burden of infectious diseases, with an estimated 10.7 million people falling ill with tuberculosis in the preceding year according to the World Health Organization's 'Global Tuberculosis Report 2025' (November 2025), further stimulates market activity by highlighting the critical need for dependable diagnostic workflows that utilize these vital consumables.

Simultaneously, heightened research and development spending across the pharmaceutical and biotechnology industries is significantly contributing to market growth. As pharmaceutical companies intensify their efforts to discover new therapeutics, the application of electrophoresis in quality control, drug characterization, and purity assessment has grown substantially. This financial dedication is exemplified by major industry players; Novartis, in its 'Annual Report 2024' (January 2025), reported allocating USD 9.3 billion to core research and development activities from its continuing operations. Such significant investments directly lead to the continuous purchase of gels, buffers, and stains, ensuring that electrophoresis remains a foundational technique in the drug discovery process, even with the advent of other technologies.

Market Challenges

The growing preference for alternative analytical technologies, specifically Next-Generation Sequencing (NGS) and High-Performance Liquid Chromatography (HPLC), directly impedes the growth of the Global Electrophoresis Reagents Market. As both pharmaceutical firms and research facilities increasingly favor these advanced techniques for their superior throughput and genomic accuracy, there is a concurrent decline in the dependence on conventional electrophoresis procedures. This shift in technology inevitably results in a lower volume of essential consumables, including gels and buffers, being procured, particularly for advanced applications where traditional separation methods are now perceived as less efficient or lacking sufficient detail.

This contraction in the market is fueled by the industry's strong move towards precision therapies, which require sophisticated diagnostic platforms over standard techniques. The Personalized Medicine Coalition reported that in 2025, personalized medicines constituted roughly 38 percent of all new therapeutic molecular entities approved by the FDA in the preceding year. This significant emphasis on intricate, data-intensive treatment approaches motivates research centers to dedicate larger portions of their budgets to NGS infrastructure instead of conventional electrophoresis setups, consequently limiting the revenue growth prospects for suppliers of traditional reagents.

Market Trends

The market is undergoing a fundamental restructuring driven by the transition towards automated electrophoresis workflows, as laboratories increasingly prioritize reproducibility and throughput over traditional manual techniques. Although manual slab gels are still prevalent in fundamental research, there is a clear move towards automated capillary systems, especially in clinical and quality control settings where data integrity and operational efficiency are crucial.

This shift is reflected in recent financial outcomes; Bio-Rad Laboratories' 'Fourth-Quarter and Full-Year 2024 Financial Results' (February 2025) showed a 3.7 percent increase in sales for its Clinical Diagnostics segment, which heavily relies on automated screening, reaching USD 1.5 billion, while the Life Science segment, largely dependent on conventional research workflows, saw a 12.6 percent decline. This disparity highlights a wider industry movement towards automated platforms that reduce human error and enhance processing speed, enabling electrophoresis to maintain its competitiveness against other technologies.

In parallel, the introduction of eco-friendly and sustainable reagents is becoming a key factor in purchasing decisions, as institutions endeavor to lessen their environmental impact. There is a growing demand from stakeholders for products that minimize hazardous waste and energy consumption, compelling manufacturers to re-engineer buffers and secure third-party sustainability certifications for their production sites.

This dedication to environmentally conscious supply chains is gaining momentum; Thermo Fisher Scientific's '2024 Corporate Social Responsibility Data Summary' (September 2025) indicated that the company substantially advanced its sustainability efforts by acquiring 24 additional My Green Lab certifications that year, totaling 51 certified facilities. This trend encourages the development of non-toxic stains and biodegradable gels, ensuring that electrophoresis remains a relevant technique in line with contemporary corporate social responsibility requirements.

Key Market Players

• Agilent Technologies, Inc.
• BioAtla, Inc.
• Bio-Rad Laboratories, Inc.
• Lonza Group Ltd.
• Merck KGaA
• Qiagen NV
• Takara Bio USA, Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Hoefer Inc.

Report Scope

In this report, the Global Electrophoresis Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Electrophoresis Reagents Market, by Product:

• Gels
• Dyes
• Buffers
• Other Products

Electrophoresis Reagents Market, by Technique:

• Gel Electrophoresis
• Capillary Electrophoresis

Electrophoresis Reagents Market, by End User:

• Academic and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Laboratories
• Other End Users

Electrophoresis Reagents Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Electrophoresis Reagents Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.